Endpoints
pain
SECONDARY
The primary endpoint was the within‐subject difference in terms of the visual analog scale (VAS) score (ranging from 0 [no pain] to 100 [worst pain]). The scores were obtained immediately before and 5 min after the first use of ibuprofen or placebo gargle on PODs 1 and 2 (ΔVASThe secondary endpoints were as follows:
Within‐subject VAS score before and 15 min after the first use of ibuprofen or placebo gargle on PODs 1 and 2 (ΔVASΔVASThe number of times of gargle use and analgesic drug (loxoprofen sodium) administration per day on PODs 1–5.Safety assessment of ibuprofen gargle.